(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

G GNA BIOSOLUTIONS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

G GNA BIOSOLUTIONS

ST13

US500000079218926

Class

5, 9, 10, 42

Filing

79218926

Registration

5705753

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

06/11/2026

Trademark type

Combined

Nice classes

5, 9, 10, 42

Filing date

07/28/2017

Registration date

03/26/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/10/2025

Last transaction

06/11/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

5

Owner type

27

Owner location

DE

Examiner

THOMAS, JULIE

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of "G GNA BIOSOLUTIONS" in stylized font.

Holders and representatives

Holders

GNA Biosolutions GmbH

Representatives

Jacqueline Zion Pearl Cohen Zedek Latzer Baratz LLP

Technical classification

Nice Classes

Class 5Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic chemical reagents for medical use; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for veterinary purposes; diagnostic biomarker reagents for medical purposes; diagnostic testing materials for medical use testing of the intended performance characteristics of bioanalytical methods; diagnostic reagents for medical use; clinical medical reagents; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use with analyzers for medical purposes

Class 9

Biochips for research or scientific purposes; diagnostic apparatusnot for medical purposesfor bioanalytical purposesin particular for nucleic acid amplification and detection; computer software applicationsdownloadablefor setting upconductinginterpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; lasersnot for medical purposes; chemistry apparatus and instrumentsfor bioanalytical procedures; recorded computer programs for setting upconducting interpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; downloadable computer software programs for setting upconductinginterpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; recorded computer software for setting upconductinginterpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; DNA chips; air analysis apparatus; optical apparatus and instrumentsfor bioanalytical measurements; laboratory equipmenttest tubes; probes for scientific purposes for conducting bioanalytical measurementsin particular for nucleic acid amplification and detection; scientificelectrotechnicalelectronicopticalmeasuringsignalingcheckingsupervision apparatus and instrumentsfor conducting bioanalytical proceduresin particular sample preparationnucleic acid amplification and detection; laboratory apparatusanalysis apparatus and parts thereforfor conducting bioanalytical proceduresin particular sample preparationnucleic acid amplification and detection; scanners; laboratory equipmentin particular apparatus for bioanalysisin particular temperature cyclersfluorescence scanners and apparatuses for nucleic acid amplification and detectionin particular using a cartridge for preparing samplespurifying nucleic acids and amplifying nucleic acids and for detecting nucleic acids; disposable articles for laboratory apparatusin particular sample and receptaclesmainly consisting of plastic; parts and fittings for all the aforesaidmechanicalelectricalstructural modules or components

Class 10

Apparatus for DNA and RNA exams for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes for detecting target molecules of interest in a samplein particular a patient sample; lasers for medical purposes; medical apparatusin particular apparatus for bioanalysisthe extractionamplificationdetection of target molecules of interest; diagnostic apparatus for veterinary purposes for detecting target molecules of interest; automatic analyzers for medical diagnosis for detecting target molecules of interest; medical apparatus and instrumentsfor detecting target molecules of interest; medical instruments for infectious disease testinghuman or veterinary pathogens; medical and veterinary apparatus and instrumentsfor processing samplesdetecting target molecules of interest; tools for veterinary diagnosticsdetecting target molecules of interest

Class 42

Updating of computer software; maintenance of software; biological research; cloud computing featuring software for setting upconductinginterpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; chemical laboratories; chemical analysis; bacteriological research; chemical research; research and development of new products for others; conducting clinical trials for others for scientific and medical research; medical and scientific research services; scientific laboratory services; clinical laboratory services for scientific purposes; scientific and technological services and research and design relating theretoconducting bioanalytical procedures; industrial analysis and research servicesconducting bioanalytical proceduresin particular nucleic acid amplification and detection for scientific research purposes; design and development of computer hardware and software; scientific analysis of cellsproteinsnucleic acids and other molecules between 50 and 10 000 daltonsfor DNA sequencing and genotypingfor detecting DNS mutationsfor gene expression profilingin particular relating to the conducting of high throughput screening methods; information and advice relating to the aforesaid services; development and conducting of scientific analyses and diagnostic methodsfor others

Publications

History of USPTO decisions and trademark events.

42 publications found

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

06/10/2026

C71T

CANCELLED SECTION 71

10/10/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/26/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/09/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/16/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/25/2019

FIMP

FINAL DISPOSITION PROCESSED

07/25/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/26/2019

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/05/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

03/26/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/20/2019

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

03/20/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/08/2019

PUBO

PUBLISHED FOR OPPOSITION

01/08/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/19/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/30/2018

ALIE

ASSIGNED TO LIE

11/29/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/08/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

11/08/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/08/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

11/08/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/08/2018

RFNP

REFUSAL PROCESSED BY IB

10/06/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/07/2018

GNRT

NON-FINAL ACTION E-MAILED

08/07/2018

CNRT

NON-FINAL ACTION WRITTEN

08/07/2018

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/09/2018

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

06/26/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/09/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/24/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/23/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/23/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/23/2018

RFNT

REFUSAL PROCESSED BY IB

12/17/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/28/2017

RFRR

REFUSAL PROCESSED BY MPU

11/28/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/15/2017

CNRT

NON-FINAL ACTION WRITTEN

11/14/2017

MAFR

APPLICATION FILING RECEIPT MAILED

10/31/2017

DOCK

ASSIGNED TO EXAMINER

10/28/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/25/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/19/2017

Continuous trademark protection

Get notified about every new filing that threatens G GNA BIOSOLUTIONS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.